Professeur Alfred Zippelius
Prof. Dr. Alfred Zippelius, MD, is full Professor of Translational Oncology and Deputy Head of the Department of Medical Oncology at the University Hospital Basel, Switzerland.
He is heading a research group focusing on translational research in the area of cancer immunology & immunotherapy at the Department of Biomedicine. In addition, he is conducting clinical trials as well as supervising clinical research.
Prof. Zippelius studied medicine at Ludwig-Maximilians-University (LMU) Munich, Germany, where he also performed experimental work for his MD thesis in the laboratory of world-renowned German Immunologist Prof. Dr. Gert Riethmüller. After this he performed post-doctoral research work as a German Funding Agency (DFG)/Emmy-Noether fellow at the Ludwig Institute for Cancer Research (LICR) in Lausanne, Switzerland, and thereafter became principal investigator in the Tumor Immunology lab of the Medical Oncology Department at University Hospital Zurich, Switzerland.
He was then appointed Swiss National Science Foundation (SNF) Professor and group leader of the Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel, where he subsequently became full Professor of Translational Oncology. He has full responsibility for clinical trial design and applications and the research in the Laboratory of Cancer Immunology.
Prof. Zippelius is author of > 150 high-impact publications and inventor of several patents in the field of cancer immunology, and during his career has received numerous fellowships and awards, including competitive DFG/Emmy-Noether fellowship, SNF Excellenza and Dora Seif Cancer Award. Prof. Zippelius is on a number of international review and advisory boards, including review functions for leading journals such as NEJM, Cell, Nature Cancer and Nature Medicine, and for national and international funding institutes. Prof. Zippelius is Section Editor at JITC and also active in many national and international professional societies.